Trials / Unknown
UnknownNCT02238535
Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effectiveness of the synthetic analogue of prostacyclin in postembolic residual pulmonary hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ventavis | |
| DRUG | Warfarin |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-03-01
- Completion
- 2016-10-01
- First posted
- 2014-09-12
- Last updated
- 2015-09-23
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02238535. Inclusion in this directory is not an endorsement.